Marrow fibrosis in myelodysplastic syndromes - Its significance in the context of the WHO classification of disease and the International Prognostic Scoring System.

被引：0
|
作者：
Buesche, G
Ganser, A
Wilkens, L
Schlegelberger, B
Hecker, H
Georgii, A
Kreipe, HH
机构：
[1] Hannover Med Sch, Inst Pathol, Hannover, Germany
[2] Hannover Med Sch, Klin Hamatol & Onkol, Hannover, Germany
[3] Hannover Med Sch, Inst Zell & Mol Pathol, Hannover, Germany
[4] Hannover Med Sch, Inst Biometrie, Hannover, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.1446.1446
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1446
引用
收藏
页码：405A / 405A
页数：1
相关论文
共 50 条
  • [31] Analysis of WHO-Based Prognostic Scoring System(WPSS) of Myelodysplastic Syndrome and Its Comparison with International Prognostic Scoring System(IPSS) in 100 Chinese Patients
    Jia Wei1
    Chinese Journal of Cancer Research, 2009, 21 (01) : 50 - 55
  • [32] Clinico-pathological analysis of myelodysplastic syndromes according to French-American-British classification and international prognostic scoring system
    Lau, LG
    Chng, WJ
    Liu, TC
    Tan, LK
    Ong, KH
    Mow, BMF
    Kueh, YK
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2004, 33 (05) : 589 - 595
  • [33] Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
    A Nazha
    M Narkhede
    T Radivoyevitch
    D J Seastone
    B J Patel
    A T Gerds
    S Mukherjee
    M Kalaycio
    A Advani
    B Przychodzen
    H E Carraway
    J P Maciejewski
    M A Sekeres
    Leukemia, 2016, 30 : 2214 - 2220
  • [34] Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
    Nazha, A.
    Narkhede, M.
    Radivoyevitch, T.
    Seastone, D. J.
    Patel, B. J.
    Gerds, A. T.
    Mukherjee, S.
    Kalaycio, M.
    Advani, A.
    Przychodzen, B.
    Carraway, H. E.
    Maciejewski, J. P.
    Sekeres, M. A.
    LEUKEMIA, 2016, 30 (11) : 2214 - 2220
  • [35] External validation of the Molecular International Prognostic Scoring System (IPSS-M) for myelodysplastic syndromes
    Chernak, Brian
    Ali, Abdullah
    Jan, Amna
    Mukherjee, Sanjay
    Jurcic, Joseph G.
    Raza, Azra
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [36] Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes
    Alkharabsheh, Omar
    Saadeh, Salwa S.
    Patnaik, Mrinal S.
    Alkhateeb, Hassan
    Gangat, Naseema
    Begna, Kebede H.
    Hogan, William J.
    Greipp, Patricia T.
    He, Rong
    Nguyen, Phuong L.
    Litzow, Mark R.
    Al-Kali, Aref
    AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (12) : E398 - E401
  • [37] CLINICIAN UTILIZATION OF THE INTERNATIONAL PROGNOSTIC SCORING SYSTEM (IPSS) FOR NEWLY DIAGNOSED MYELODYSPLASTIC SYNDROMES (MDS) PATIENTS
    Pease, D.
    Ross, J.
    Poynter, J.
    Nguyen, P.
    Hirsch, B.
    Cioc, A.
    Roesler, M.
    Warlick, E.
    LEUKEMIA RESEARCH, 2015, 39 : S118 - S118
  • [38] Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes
    Montoro, Julia
    Pomares, Helena
    Villacampa, Guillermo
    Merchan, Brayan
    Molero, Antonieta
    Alonso, Esther
    Gallur, Laura
    Grau, Javier
    Salamero, Olga
    Roldan, Elisa
    Saumell, Silvia
    Ortega, Margarita
    Sureda, Anna
    Bosch, Francesc
    Arnan, Montserrat
    Valcarcel, David
    LEUKEMIA & LYMPHOMA, 2019, 60 (06) : 1522 - 1527
  • [39] Improved risk stratification by the integration of the revised International Prognostic Scoring System with the Myelodysplastic Syndromes Comorbidity Index
    van Spronsen, M. F.
    Ossenkoppele, G. J.
    Holman, R.
    van de Loosdrecht, A. A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (18) : 3198 - 3205
  • [40] Prognostic Performance of the Cytogenetic Risk Classification Defined by the German-Austrian Myelodysplastic Syndromes (MDS) Study Group and Its Contribution to the International Prognostic Scoring System (IPSS) and the World Health Organization-Based Prognostic Scoring System (WPSS).
    Nomdedeu, Benet
    Nomdedeu, Meritxell
    Pereira, Arturo
    Costa, Dolors
    Carrio, Anna
    Calvo, Xavier
    Belkaid, Mohamed
    Cobo, Francesc
    Urbano-Ispizua, Alvaro
    BLOOD, 2010, 116 (21) : 1633 - 1633
12345